pbs
dermatology
PBS
pharmaceutical
‘Unsustainable’: Pfizer pulls out of JAKi PBS application
Hidradenitis Suppurativa
PBS
PBS recommendations for bimekizumab, guselkumab
Atopic Dermatitis
pharmaceutical
Eli Lilly pulls PBS application for eczema drug
PBS
New authority requirement adding to the PBS ‘clickfest’
pharmaceutical
Political
Eli Lilly exec says slow PBS threatens clinical trials funding
PBS
psoriatic arthritis
Risankizumab added to PBS for psoriatic arthritis
dermatology
Top 10 Dermatology Republic stories for 2024: see what made the list
PBS
‘Breakthough’ as first targeted lupus drug hits PBS
PBS